2nd Quarter - Report

HPS GROUP, LLC for ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE)

Period 2nd Quarter 2024 Filed Aug 13, 2024 Signed by Steven Grossman

Official filing
Firm
HPS GROUP, LLC
Client
ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE)
Income
$15,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Increased BA appropriations for the US Food and Drug Administration

LobbyistCovered position, as disclosed
STEVEN GROSSMAN —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.